cll: sequencing monotherapy vs. combination therapy
Published 5 years ago • 1.1K plays • Length 21:19Download video MP4
Download video MP3
Similar videos
-
19:04
cll: sequencing decisions using current therapy options
-
24:17
combination of novel agents in cll: is this the final answer?
-
22:47
the sequencing of novel agents: does it matter?
-
1:29
the importance of treatment sequencing in cll
-
9:48
optimal combination and sequence of chronic lymphocytic leukemia therapies
-
23:25
velocity vlog: transforming the diagnosis and treatment of cll
-
25:38
cll: chemotherapy and ibrutinib based regimens
-
27:18
novel treatment options in cll
-
26:34
chronic lymphocytic leukemia: mrd updates
-
7:20
therapeutic sequencing in cll
-
15:02
debate: will novel-agent based combination therapy become standard of care for cll? - no
-
17:22
varying efficacies of combination and monotherapies in cll
-
29:14
ibrutinib resistance-mechanisms and options in cll
-
35:31
cll: btk inhibitors in hematologic oncology pathways - pathway-guided choices
-
19:42
treatment options for the young cll patient with deletion 17p: do they need a different approach?
-
1:11
combining and sequencing agents in cll
-
24:09
update on venetoclax for cll
-
4:57
sequencing of targeted therapies for cll
-
3:29
small molecule inhibitors for cll: which to use, sequencing, switching and combinations